Xiaodong Lian

Xiaodong Lian

Auto-generated profile, based on publicly available information

Xiaodong Lian

Ragon Institute of MGH, MIT and Harvard, Cambridge, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cell
Verified
Journal Article
Closed access
NKNaoki Kaneko
Naoki Kaneko
HKHsiao-Hsuan Kuo
Hsiao-Hsuan Kuo
JBJulie Boucau
Julie Boucau
JFJocelyn R. Farmer
Jocelyn R. Farmer
HAHugues Allard-Chamard
Hugues Allard-Chamard
SPShiv Pillai
Shiv Pillai

26 August 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CJChenyang Jiang
Chenyang Jiang
XLXiaodong Lian
Xiaodong Lian
CGCe Gao
Ce Gao
XSXiaoming Sun
Xiaoming Sun
KEKevin B. Einkauf
Kevin B. Einkauf
XYXu G. Yu
Xu G. Yu

12 January 2022 in Cell
Verified
Journal Article
Open access
KEKevin B. Einkauf
Kevin B. Einkauf
MOMatthew R. Osborn
Matthew R. Osborn
CGCe Gao
Ce Gao
WSWeiwei Sun
Weiwei Sun
XSXiaoming Sun
Xiaoming Sun
MLMathias Lichterfeld
Mathias Lichterfeld
HIV-1-infected cells that persist despite antiretroviral therapy (ART) are frequently considered “transcriptionally silent,” but active viral gene expression may occur in some cells, challenging the concept of viral latency. Applying an assay for profiling the transcriptional activity and the chromosomal locations of individual proviruses, we describe a global genomic and epigenetic map of transcriptionally active and silent proviral species and evaluate their longitudinal evolution in persons receiving suppressive ART. Using genome-wide epigenetic reference data, we show that proviral transcriptional activity is associated with activating epigenetic chromatin features in linear proximity of integration sites and in their inter- and intrachromosomal contact regions. Transcriptionally active proviruses were actively selected against during prolonged ART; however, this pattern was violated by large clones of virally infected cells that may outcompete negative selection forces through elevated intrinsic proliferative activity. Our results suggest that transcriptionally active proviruses are dynamically evolving under selection pressure by host factors.

4 January 2023 in Nature
Verified
Journal Article
Open access
PDF file
WSWeiwei Sun
Weiwei Sun
CGCe Gao
Ce Gao
CHCiputra Adijaya Hartana
Ciputra Adijaya Hartana
MOMatthew R. Osborn
Matthew R. Osborn
KEKevin B. Einkauf
Kevin B. Einkauf
MLMathias Lichterfeld
Mathias Lichterfeld
Human immunodeficiency virus 1 (HIV-1) reservoir cells persist lifelong despite antiretroviral treatment1,2but may be vulnerable to host immune responses that could be exploited in strategies to cure HIV-1. Here we used a single-cell, next-generation sequencing approach for the direct ex vivo phenotypic profiling of individual HIV-1-infected memory CD4+T cells from peripheral blood and lymph nodes of people living with HIV-1 and receiving antiretroviral treatment for approximately 10 years. We demonstrate that in peripheral blood, cells harbouring genome-intact proviruses and large clones of virally infected cells frequently express ensemble signatures of surface markers conferring increased resistance to immune-mediated killing by cytotoxic T and natural killer cells, paired with elevated levels of expression of immune checkpoint markers likely to limit proviral gene transcription; this phenotypic profile might reduce HIV-1 reservoir cell exposure to and killing by cellular host immune responses. Viral reservoir cells harbouring intact HIV-1 from lymph nodes exhibited a phenotypic signature primarily characterized by upregulation of surface markers promoting cell survival, including CD44, CD28, CD127 and the IL-21 receptor. Together, these results suggest compartmentalized phenotypic signatures of immune selection in HIV-1 reservoir cells, implying that only small subsets of infected cells with optimal adaptation to their anatomical immune microenvironment are able to survive during long-term antiretroviral treatment. The identification of phenotypic markers distinguishing viral reservoir cells may inform future approaches for strategies to cure and eradicate HIV-1.

15 December 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
XLXiaodong Lian
Xiaodong Lian
CGCe Gao
Ce Gao
XSXIAOMING SUN
XIAOMING SUN
CJChenyang Jiang
Chenyang Jiang
KEKevin B. Einkauf
Kevin B. Einkauf
XYXu G. Yu
Xu G. Yu
Immune selection footprints in proviral sequences distinguish individuals with natural, drug-free control of HIV-1.

16 November 2021 in Annals of Internal Medicine
Verified
Journal Article
Closed access
GTGabriela Turk
Gabriela Turk
KSKyra Seiger
Kyra Seiger
XLXiaodong Lian
Xiaodong Lian
WSWeiwei Sun
Weiwei Sun
EPElizabeth M. Parsons
Elizabeth M. Parsons
XYXu G. Yu
Xu G. Yu
A sterilizing cure of HIV-1 infection has been reported in 2 persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplant, but such a cure has been elusive during natural i... Background: A sterilizing cure of HIV-1 infection has been reported in 2 persons living with HIV-1 who underwent allogeneic hematopoietic stem cell transplantations from donors who were homozygous ...